Sarah R. Bujac

Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

D Flavell, Inès Pineda‐Torra, Yalda Jamshidi et al. · Diabetologia · 2000 · 170 citations · Full text

Metabolic Syndrome, Genetics, Physiology +10

Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?

Bruce K. Birmingham, Sarah R. Bujac, Robert Elsby et al. · European Journal of Clinical Pharmacology · 2015 · 146 citations

Cardiovascular Disease, Medicine, Genetic Epidemiology +11

Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States

Bruce K. Birmingham, Sarah R. Bujac, Robert Elsby et al. · European Journal of Clinical Pharmacology · 2015 · 136 citations

Translational Medicine, Cardiovascular Disease, Medicine +7

Genetic and Environmental Determinants of Plasma Nitrogen Oxides and Risk of Ischemic Heart Disease

Noor Jeerooburkhan, Lisa C. Jones, Sarah R. Bujac et al. · Hypertension · 2001 · 123 citations

Hypertension, Genetic Epidemiology, Human Polymorphism +23

Further Evidence of Association of OPRD1 & HTR1D Polymorphisms with Susceptibility to Anorexia Nervosa

Kirsty Brown, Sarah R. Bujac, Evleen T. Mann et al. · Biological Psychiatry · 2006 · 89 citations

Psychopathology, Psychiatry, Eating Disorders +8